Clinical Trials Directory

Trials / Completed

CompletedNCT02287493

Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In a prospective, non-interventional, monocentric observational study the pharmacokinetic properties of selected antiinfective drugs during sustained low-efficiency dialysis (SLED) will be analyzed.

Detailed description

Antibiotic concentrations are measured whilst patients receive SLED for renal replacement therapy. The plasma specimens will be quantified using high Performance liquid chromatography (HPLC). Primary endpoint: \- Plasma levels of antiinfectives during SLED Secondary endpoints: * mortality * length of stay at the intensive care unit (ICU) and hospital * clinical cure of infections Inclusion criteria: * age: \> 18 years * patients under SLED * antiinfective treatment exclusion criteria: \- missing informed consent

Conditions

Interventions

TypeNameDescription
OTHERPharmacokinetic Analysis

Timeline

Start date
2013-07-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-11-10
Last updated
2021-12-14
Results posted
2021-02-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02287493. Inclusion in this directory is not an endorsement.